Lotus Pharmaceuticals, Inc (LTUS) fair value: what the stock is really worth
As of Nov 13, 2026: fair value (intrinsic value) of Lotus Pharmaceuticals, Inc stock $0.00, price $0.00, upside +6.8%, quality 58 out of 100. Rating: fairly valued. Calculated from audited financials with one of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Lotus Pharmaceuticals, Inc
LTUS · USSolid company, but the stock is already about fairly priced and falling price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
60‑month range $0.0006 – $0.0479 · the $0.0031 price screens below the $0.0033 fair value. As of Nov 16, 2026.
Every Wednesday you see whether Lotus Pharmaceuticals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Lotus Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development, manufacture, and sale of pharmaceuticals in the People's Republic of China.
Show moreShow less
The company was formerly known as S.E. Asia Trading, Inc. and changed its name to Lotus Pharmaceuticals, Inc. in December 2006. Lotus Pharmaceuticals, Inc. is based in Irvine, California.
Stock analysis
Lotus Pharmaceuticals, Inc (LTUS) currently trades at $0.0031, while our model-based Fair Value estimate is $0.0033, so the stock looks roughly fairly valued today (gap 6.4%).
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the data coverage at low.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Financial Services sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Lotus Pharmaceuticals, Inc reported revenue of $72.7M in FY2010 versus $36.2M in FY2006, a compound +19.0%/yr. Reported net income was −$29.0K in FY2025.
Key figures
Market cap $8.1M Micro · P/S ratio 0.15 · EPS (TTM) $−0.0500 · Return on equity 1.8% · Return on assets (EBIT) −389% (3-year average) · Operating margin 6.7% · Revenue (TTM) $71.4M · Revenue growth (YoY) +4.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (low confidence).
What moves the price
The share trades about 48% below its 52-week high and 72% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −53% fair-value upside, at 7%, LTUS screens cheaper than that median.
Fair Value models
All 1 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Watch LTUS, get fair value alerts →
Compare Lotus Pharmaceuticals, Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 44 stocks
Valuation Multiplesvs Shell Companies median · lower = cheaper
Strength profile in five axes (Snowflake)
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- PEG ratio by industry
- Revenue growth by industry
- Stock screener with 62 metrics
- Undervalued stocks: US Stocks
- Valuation of the USA market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Shell Companies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Metals Acquisition Corp MTAL | $10.15 | $17.26 | +70% | vs LTUS |
| AA Mission Acquisition Corp AAM | $0.0290 | $0.0390 | +34% | vs LTUS |
| Cantor Equity Partners I, Inc CEPO | $10.81 | $9.56 | −12% | vs LTUS |
| Lionheart III Corp LION | $14.04 | $9.72 | −31% | vs LTUS |
| Texas Ventures Acquisition III Corp TVACW | $0.1800 | $0.0850 | −53% | vs LTUS |
| Translational Development Acquisition Corp TDAC | $10.86 | $4.28 | −61% | vs LTUS |
| Lionheart Holdings CUBWU | $11.08 | $4.36 | −61% | vs LTUS |
| Berto Acquisition Corp TACO | $10.52 | $2.32 | −78% | vs LTUS |
| Vylor Inc VYLR | $71.80 | $14.24 | −80% | vs LTUS |
| Axiom Intelligence Acquisition Corp AXIN | $10.41 | $1.24 | −88% | vs LTUS |
Explore undervalued stocks
More undervalued Financial Services stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Lotus Pharmaceuticals, Inc (LTUS) overvalued or undervalued?
What is the fair value of LTUS?
What is the quality score of LTUS?
What is the price target for Lotus Pharmaceuticals, Inc (LTUS)?
What is the Lotus Pharmaceuticals, Inc stock forecast for 2026?
What is the revenue of Lotus Pharmaceuticals, Inc (LTUS)?
What is the intrinsic value of Lotus Pharmaceuticals, Inc (LTUS)?
Is Lotus Pharmaceuticals, Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of LTUS?
How much is Lotus Pharmaceuticals, Inc worth?
How solid is the balance sheet of Lotus Pharmaceuticals, Inc (LTUS)?
How far is LTUS from its 52-week high?
Which stocks are comparable to Lotus Pharmaceuticals, Inc?
Is Lotus Pharmaceuticals, Inc stock attractive at the current price?
How is the fair value of LTUS calculated?
Is it still worth investing in stocks now?
What is the share price of Lotus Pharmaceuticals, Inc (LTUS)?
What should I pay attention to with Lotus Pharmaceuticals, Inc right now?
Key figures of Lotus Pharmaceuticals, Inc
How large is the market capitalisation of Lotus Pharmaceuticals, Inc (LTUS)?
What is the P/S ratio of Lotus Pharmaceuticals, Inc (LTUS)?
What are the earnings per share of Lotus Pharmaceuticals, Inc (LTUS)?
What is the return on equity of Lotus Pharmaceuticals, Inc (LTUS)?
What is the EBIT return on assets of Lotus Pharmaceuticals, Inc (LTUS)?
What is the operating margin of Lotus Pharmaceuticals, Inc (LTUS)?
How fast is revenue growing at Lotus Pharmaceuticals, Inc (LTUS)?
How fast are earnings growing at Lotus Pharmaceuticals, Inc (LTUS)?
How much free cash flow does Lotus Pharmaceuticals, Inc (LTUS) generate?
How much net debt does Lotus Pharmaceuticals, Inc (LTUS) carry?
Watch Lotus Pharmaceuticals, Inc in the live analysis
One click puts Lotus Pharmaceuticals, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.